Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies.
about
Tonic shock induces detachment of Giardia lambliaPhysiological parameters for oral delivery and in vitro testingSurface tension examination of various liquid oral, nasal, and ophthalmic dosage formsProtein Corona-Induced Modification of Silver Nanoparticle Aggregation in Simulated Gastric Fluid.Gastrointestinal biodurability of engineered nanoparticles: Development of an in vitro assayRapid Kinetics of Size and pH-Dependent Dissolution and Aggregation of Silver Nanoparticles in Simulated Gastric Fluid.Formation of reactive aldehydes (MDA, HHE, HNE) during the digestion of cod liver oil: comparison of human and porcine in vitro digestion models.Hyperosmolarity in the small intestine contributes to postprandial ghrelin suppressionThe use of biorelevant dissolution media to forecast the in vivo performance of a drug.Time of ingestion relative to meal intake determines gastrointestinal responses to a plant sterol-containing yoghurt drink.A single-component multidrug transporter of the major facilitator superfamily is part of a network that protects Escherichia coli from bile salt stress.Disintegration of solid foods in human stomach.Acidic digestion in a teleost: postprandial and circadian pattern of gastric pH, pepsin activity, and pepsinogen and proton pump mRNAs expression.Human Gastrointestinal Juices Intended for Use in In Vitro Digestion Models.Toward an in vivo dissolution methodology: a comparison of phosphate and bicarbonate buffers.Effects of dietary factors on iron uptake from ferritin by Caco-2 cells.Potential of lactoferrin to prevent antibiotic-induced Clostridium difficile infectionA new method for determining gastric acid output using a wireless pH-sensing capsule.Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption.Predicting pharmacokinetics of drugs using physiologically based modeling--application to food effectsFDA critical path initiatives: opportunities for generic drug development.pH-Dependent Solubility and Dissolution Behavior of Carvedilol--Case Example of a Weakly Basic BCS Class II Drug.Controlling lipid bioavailability through physicochemical and structural approaches.Ambient tonicity and intestinal cytochrome CYP3A.A biorelevant dissolution stress test device - background and experiences.Biorelevant in-vitro performance testing of orally administered dosage forms.Dissolution testing of oral modified-release dosage forms.Pros and cons of methods used for the prediction of oral drug absorption.Specificity of infant digestive conditions: some clues for developing relevant in vitro models.Excipient foods: designing food matrices that improve the oral bioavailability of pharmaceuticals and nutraceuticals.Drug release from matrix tablets: physiological parameters and the effect of food.Functional food microstructures for macronutrient release and delivery.Self-assembled structures formed during lipid digestion: characterization and implications for oral lipid-based drug delivery systems.In vitro-in vivo correlations: general concepts, methodologies and regulatory applications.Impact of gastric pH profiles on the proteolytic digestion of mixed βlg-Xanthan biopolymer gels.Ferritin cage for encapsulation and delivery of bioactive nutrients: From structure, property to applications.Resilience in the Face of Uncertainty: Sigma Factor B Fine-Tunes Gene Expression To Support Homeostasis in Gram-Positive BacteriaMechanistic prediction of food effects for Compound A tablet using PBPK model.Infant digestion physiology and the relevance of in vitro biochemical models to test infant formula lipid digestion.Excitability and Synaptic Transmission in the Enteric Nervous System: Does Diet Play a Role?
P2860
Q27306960-4417C386-B013-40F5-AC30-A0CB56417F2CQ27687044-CAEA2C09-08EB-4B3D-B254-DACD5454B7CAQ28833256-FF734597-6BEA-4D24-BB09-11857C5FFDD8Q30400476-A851AF6A-C519-4014-BB36-60D6D2BBDF78Q30431391-3BE00D38-3979-4363-8761-387C91A756CFQ30843529-38571A76-CD38-40CF-8AEC-4029C291DC0BQ33467115-34138885-9ADA-4B32-9564-88CAA4E0FA95Q33764587-9EB10D14-1711-4640-8FC3-28DCF66F72D8Q33954607-856659A8-33E3-41CC-8472-951B66F3A7E8Q34390280-54577DBE-BF0D-4ED7-B61B-F598D69A4D5BQ34531336-90221D8B-A1DD-4B27-BCE9-768315830C8CQ34788774-2AB0EB1B-BAE3-4960-9E06-673DDC0BA8C9Q35842546-3CAB45F0-4F5A-4F0F-8326-061054F02CDAQ35920619-32F9CD0F-B047-458A-BD0D-FA594B29CB36Q35940550-C15B4B1E-A953-466C-BCEF-7A9A40741618Q36491017-2F569864-1926-4BCB-A22B-258B0FEF3AB8Q36684188-DE8A1C46-EF38-4ECA-8952-4FFCA476E4CBQ36990067-ECB25B24-6E5B-4706-B008-9172A88CC4E3Q37058658-E35D57C9-BE64-41CC-9DC0-B05D44E07CD9Q37149095-8F4E4AF2-52A6-4DD3-921A-6C6E6D7B2CBEQ37150863-0CEDCA5B-8F8D-4738-9648-C7A9818F7B4BQ37174993-0C37C13E-B971-4ED4-A632-358B13BDD8A0Q37307707-FD640AE4-645A-441F-824A-4804DFDC6485Q37725997-050AD203-E32C-428C-A650-E54019851058Q37803213-F40336D4-9595-4965-866A-235E448E67BDQ38017705-2E18C447-FA25-4CE3-A7B0-99210FCFC772Q38017706-41603387-C853-48B5-A155-DAE4DBB54E7FQ38177366-2BE1D1E9-588A-4EA7-99EB-A4AD36FCE8FFQ38192074-2DC5268E-2278-4D76-947A-11EE386BD6A0Q38206716-19A8A750-3526-4B8B-A76E-0E9EFE0A3E2BQ38223664-DFE8C8D4-1246-4D05-99E1-D156EA5B2E3FQ38305635-784CB2D1-BC50-4942-A9E9-9D9611A7D2D1Q38383061-1081D1CD-65E9-48F9-9AA8-31B1F3ED3645Q38541574-AA3F76C8-A05A-4913-8E8A-640F95B2A4AAQ38645280-007E88A9-86A5-40C5-9543-9F6656E44DBBQ38776237-FB3EC245-CA41-4E81-9DC5-384944A4C4DEQ38840522-4B9817E9-65F3-4EC5-9B8B-C8ECBF095D7DQ38848902-57BB3F26-5676-4289-AA9A-284786F2D10FQ38859692-AC1CF157-1BE6-437B-877C-7C149B3CCB9DQ38886444-A7F65064-1A5B-4243-B09E-7365F29D7ADD
P2860
Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Characterization of the human ...... bility/bioequivalence studies.
@en
Characterization of the human ...... bility/bioequivalence studies.
@nl
type
label
Characterization of the human ...... bility/bioequivalence studies.
@en
Characterization of the human ...... bility/bioequivalence studies.
@nl
prefLabel
Characterization of the human ...... bility/bioequivalence studies.
@en
Characterization of the human ...... bility/bioequivalence studies.
@nl
P2093
P1476
Characterization of the human ...... bility/bioequivalence studies.
@en
P2093
Bertil Abrahamsson
Christos Reppas
Jennifer B Dressman
Konstantinos Goumas
Lida Kalantzi
Vasilios Kalioras
P304
P356
10.1007/S11095-005-8476-1
P577
2006-01-01T00:00:00Z